UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone

Clinical trial NCT03139747 · SUSPENDED

Trial details

NCT number

NCT03139747

Sponsor

Thomas Jefferson University

Status

SUSPENDED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2017-04-03

Primary completion

2022-05-30

Enrollment

5

View on ClinicalTrials.gov